Skip to main content

Galderma Group

Galderma Group is a Swiss specialized dermatology company dedicated to delivering medical and aesthetic solutions for skin health worldwide. The enterprise organizes its global operational activities into three primary business categories: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Its commercial portfolio includes injectable neuromodulators and dermal fillers such as Dysport and Restylane, alongside skincare brands Cetaphil and specialized prescription acne treatments. Principal revenue drivers consist of global wholesale sales of aesthetic products, premium skincare lines, and prescription dermatological treatments to healthcare professionals, pharmacies, and retail channels. The company holds a prominent market position globally within aesthetic medicine and specialized dermatological skin care products. Galderma Group is headquartered in Zug, Switzerland, and its ordinary shares are publicly traded on the SIX Swiss Exchange under ticker symbol GALD.

90 of the funds FundTelligence covers report a position in Galderma Group.

Legal name
Galderma Group AG
Sector
Health Care
Country
Switzerland
Funds holding it
90

Funds holding Galderma Group

Showing the 8 largest of 90 funds holding it.

Loading...